Publication:
Lower urinary tract symptoms and its potential relation with late-onset hypogonadism

dc.contributor.authorPradidarcheep W.
dc.date.accessioned2021-04-05T04:31:58Z
dc.date.available2021-04-05T04:31:58Z
dc.date.issued2008
dc.date.issuedBE2551
dc.description.abstractThe study of the health status of the aging male takes presently a more integrative approach and it appears that ailments typical of male aging, such as lower urinary tract symptoms (LUTS), (visceral) obesity, metabolic syndrome and erectile failure are significantly interrelated. A common denominator of the above ailments is lower-than-normal testosterone levels occurring in a significant proportion of elderly men. This review addresses the potential connections between LUTS and late-onset hypogonadism. In animal studies there appear to be androgen and estrogen receptors in the urothelium and smooth muscle cells of the urethra and bladder of the rat and rabbit, as well as in the neurons in the autonomic ganglia of the prostatic plexus of the male rat. Upon castration electrically evoked relaxations of the smooth muscle of the prostatic urethra were decreased. There is a Rho-kinase activation/endothelin pathway; possibly involved in the increased smooth muscle activity found in both LUTS/benign prostate hyperplasia. Nitric oxide (NO) appears to have a smooth muscle relaxing effect in the urogenital organs. Studies in humans have convincingly shown that phosphodiestererase inhibitors have a beneficial effect on LUTS. More intervention studies should be undertaken to test the clinical validity of the theoretically plausible interrelationship between LUTS and late-onset hypogonadism. © 2008 Informa UK Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationAging Male. Vol 11, No.2 (2008), p.51-55
dc.identifier.doi10.1080/13685530801954026
dc.identifier.issn13685538
dc.identifier.other2-s2.0-45849140201
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3999
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherAndrogen receptor
dc.subject.otherAngiotensin II
dc.subject.otherEndothelin
dc.subject.otherEstrogen receptor
dc.subject.otherNitric oxide
dc.subject.otherRho kinase
dc.subject.otherTestosterone
dc.subject.otherAging
dc.subject.otherCastration
dc.subject.otherDisease course
dc.subject.otherEnzyme activation
dc.subject.otherEnzyme activity
dc.subject.otherHuman
dc.subject.otherHypogonadism
dc.subject.otherLower urinary tract symptom
dc.subject.otherNonhuman
dc.subject.otherNote
dc.subject.otherPriority journal
dc.subject.otherProstate hypertrophy
dc.subject.otherAge of Onset
dc.subject.otherAging
dc.subject.otherAnimals
dc.subject.otherHumans
dc.subject.otherHypogonadism
dc.subject.otherIntra-Abdominal Fat
dc.subject.otherMale
dc.subject.otherMetabolic Syndrome X
dc.subject.otherNitric Oxide
dc.subject.otherRabbits
dc.subject.otherRats
dc.subject.otherReceptors, Androgen
dc.subject.otherTestosterone
dc.subject.otherUrinary Tract
dc.subject.otherUrination Disorders
dc.titleLower urinary tract symptoms and its potential relation with late-onset hypogonadism
dc.typeNote
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-45849140201&doi=10.1080%2f13685530801954026&partnerID=40&md5=38fd859477a0e456809c781593e8588b

Files